Consortium to Enable Mass Screening for Radiation

A consortium headed by Columbia University Medical Center and involving Sionex Corp. (www.sionex.com) has been awarded a $25 million grant to develop new technologies to rapidly screen large numbers of people for radiation exposure in the event of a terrorist attack on a nuclear facility or detonation of a radiological "dirty bomb." The grant was given to the National Institute of Allergy and Infectious Diseases (NIAID) through the National Institute of Health (NIH). Over the next five years, the team will develop new devices that can assess, rapidly following a potentially catastrophic radiological incident, the radiation doses received by hundreds of thousands of individuals.

Sionex will lead the development and commercialization of a handheld device for noninvasive screening for radiation exposure. According to Anthony D. Bashall, vice president of marketing and business development at Sionex, "The device will analyze sweat, urine, or saliva samples to detect and identify metabolites which are indicative of radiation exposure." The company's technology is currently used to detect chemical and biological warfare agents, explosives, toxic compounds, and narcotics with low-cost portable devices.

Free Monthly Newsletter

Compelling read? Subscribe to FierceEmbeddedTech!

The embedded tech sector runs the market’s trends. FierceEmbeddedTech subscribers rely on our suite of newsletters as their must-read source for the latest news, developments and analysis impacting their world. Sign up today to get news and updates delivered to your inbox and read on the go.

Suggested Articles

Intel also bought Nervana for AI in 2016

Semiconductor supplier Analog Devices Inc. has sued Xilinx for violating its converter patents.

Radiative sky cooling effect helps team harvest heat let off by buildings to convert to electricity and light